» Articles » PMID: 17291936

Roles of Rho-associated Kinase and Oxidative Stress in the Pathogenesis of Aortic Stiffness

Abstract

Objectives: The purpose of this study was to determine the relationship between Rho-associated kinase (ROCK) activity and aortic stiffness in humans.

Background: Epidemiologic studies have shown that there is a relationship between aortic stiffness and cardiovascular complications. Recent evidence suggests that ROCK plays an important role in the process of atherosclerosis.

Methods: We evaluated the forearm blood flow (FBF) response to sodium nitroprusside (SNP), a nitric oxide donor, acetylcholine (ACh), an endothelium-dependent vasodilator, and fasudil, a specific ROCK inhibitor, in 51 healthy male subjects (mean age 45.6 +/- 3.0 years). The FBF was measured by using a strain-gauge plethysmography. Carotid-femoral pulse wave velocity (cf-PWV) was measured to assess the aortic stiffness using a pulse wave velocimeter.

Results: Intra-arterial infusion of SNP alone, ACh alone, or fasudil alone and after co-infusion of N(G)-monomethyl-L-arginine (L-NMMA), a nitric-oxide synthase inhibitor, significantly increased FBF in a dose-dependent manner (p < 0.01). Multivariate analysis showed that age and number of pack-years smoked were independent predictors of ROCK activity before or after co-infusion of L-NMMA (p < 0.01) and that age and ROCK activity before or after co-infusion of L-NMMA were independent predictors of cf-PWV (p < 0.01). The concentration of serum malondialdehyde-modified low-density lipoprotein, an index of oxidative stress, was significantly correlated with ROCK activity before and after co-infusion of L-NMMA and cf-PWV (p < 0.01).

Conclusions: These findings suggest that aging and accumulating smoking habit, which might induce excessive oxidative stress, are involved in ROCK activity in the vasculature, leading to an increase in aortic stiffness in humans.

Citing Articles

Noninvasive Assessment of Vascular Function: From Physiological Tests to Biomarkers.

Higashi Y JACC Asia. 2025; 4(12):898-911.

PMID: 39802992 PMC: 11711812. DOI: 10.1016/j.jacasi.2024.09.015.


Rho-kinase inhibition reduces systolic blood pressure and forearm vascular resistance in healthy older adults: a double-blind, randomized, placebo-controlled pilot study.

Bachman N, Ketelhut N, Blomquist M, Terwoord J Geroscience. 2024; 46(6):6317-6329.

PMID: 38888876 PMC: 11494619. DOI: 10.1007/s11357-024-01240-x.


RhoA/rho kinase pathway activation in age-associated endothelial cell dysfunction and thrombosis.

Palomo I, Wehinger S, Andres V, Garcia-Garcia F, Fuentes E J Cell Mol Med. 2024; 28(8):e18153.

PMID: 38568071 PMC: 10989549. DOI: 10.1111/jcmm.18153.


Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213).

Suddala S, OConnell N, DAgostino Jr R, Ladd A, Lucas A, Jordan J JACC CardioOncol. 2023; 5(5):704-706.

PMID: 37969653 PMC: 10635869. DOI: 10.1016/j.jaccao.2022.11.018.


Serum Malondialdehyde-Oxidized Low-Density Lipoprotein Level Is Associated with Arterial Stiffness by Cardio-Ankle Vascular Index in Coronary Artery Bypass Graft Patients.

Hung T, Jhan J, Lin J, Yang K, Hsu B, Chang J J Clin Med. 2023; 12(13).

PMID: 37445227 PMC: 10342905. DOI: 10.3390/jcm12134191.


References
1.
Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T . Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997; 389(6654):990-4. DOI: 10.1038/40187. View

2.
Jin L, Liu T, Lagoda G, Champion H, Bivalacqua T, Burnett A . Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. FASEB J. 2006; 20(3):536-8. DOI: 10.1096/fj.05-4232fje. View

3.
Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y . Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol. 2000; 278(1):C57-65. DOI: 10.1152/ajpcell.2000.278.1.C57. View

4.
Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, CHUN T . Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation. 2000; 101(17):2030-3. DOI: 10.1161/01.cir.101.17.2030. View

5.
Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A . Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000; 356(9237):1213-8. DOI: 10.1016/s0140-6736(00)02783-5. View